HealthQuill US
The use of marijuana and hallucinogens rose to a five-year high in younger adults between 19 and 30 years during the last year in the US, a study revealed.
Drugs Health Pharma

Use of marijuana, hallucinogens rise among young adults in the US

HQ Team August 17, 2023: The use of marijuana and hallucinogens rose to a five-year high in younger adults between 19 and 30.

Read More
Biomedical engineers at Johns Hopkins have developed a machine-learning model, which can turn on genes —an innovation which in future can fight cancer and diabetes.
Drugs Health Pharma

Biomedical engineers create ML model to turn genes on and off

HQ Team August 14, 2023: Biomedical engineers at Johns Hopkins have developed a machine-learning model, which can turn on genes —an innovation which.

Read More
An intense blaze that roared through Hawaii has killed about 93 people and authorities have issued new rehabilitation policies in the islands after the US nation’s largest wildfire tragedy.
Climate Health Pharma

Hawaii orders new rehabilitation policies, wildfire death toll at 96

HQ Team August 14, 2023: An intense blaze that roared through Hawaii, the largest wildfire tragedy in the US since 1918, has killed.

Read More
Firefighters were putting out flares and desperately trying to contain wildfires in the worst-affected regions of Hawaii as the fatalities rose to 80 and the Attorney General announced a probe, according to the government.
Climate Health Pharma

Wildfire death toll in Hawaii climbs to 80, AG orders probe

HQ Team August 13, 2023: Firefighters were putting out flares and desperately trying to contain wildfires in the worst-affected regions of Hawaii as.

Read More
A wildfire sweeping across Hawaii’s Maui town of Lahaina has killed at least 67 people, with 12 more fatalities being confirmed, according to the government.
Climate Health Pharma

Hawaii wildfire death toll rises to 67, fires still burning

HQ Team August 12, 2023: A wildfire sweeping across Hawaii’s Maui town of Lahaina has killed at least 67 people, with 12 more.

Read More
The WHO has updated the EG.5 variability of the COVID-19 virus to a ‘variant of interest’ — with genetic changes that are predicted or known to affect virus characteristics, such as transmissibility, virulence, antibody evasion, susceptibility to therapeutics and detectability.
Drugs Health Pharma

WHO labels Covid-19 variant EG.5 as ‘variant of interest’; cases rise

HQ Team August 10, 2023: The WHO has updated the EG.5 variability of the COVID-19 virus to a ‘variant of interest’ — with.

Read More
Anixa Biosciences, Inc., announced that its partner Cleveland Clinic has begun enrolling subjects in a treatment arm to evaluate the combination of the company's breast cancer vaccine with Merck’s Keytruda (pembrolizumab) immunotherapy.
Drugs Health Pharma

Anixa to conduct breast cancer trials with Merck’s Keytruda therapy

HQ Team August 7, 2023: Anixa Biosciences, Inc., announced that its partner Cleveland Clinic has begun enrolling subjects in a treatment arm to.

Read More
US researchers have developed a targeted chemotherapy method that may decimate all solid tumors in animals at a laboratory, and a trial has started to test it on humans.
Drugs Health Pharma

US researchers develop novel chemotherapy cancer treatment

HQ Team August 5, 2023: US researchers have developed a targeted chemotherapy method that may decimate all solid tumors in animals at a.

Read More
The US medical research agency has opened enrollment for the second stage of trials to evaluate about four treatments for long-Covid-19 and plans another seven treatment tests in the near future.
Drugs Health Pharma

Enrollment for test trials to find long Covid-19 treatment starts in US

HQ Team August 1, 2023: The US medical research agency has opened enrollment for the second stage of trials to evaluate about four treatments.

Read More
Biogen Inc., a US-based biotechnology company, will acquire Reata Pharmaceuticals for $7.3 billion to expand its neurological portfolio, according to a company statement
Drugs Health Pharma

Biogen Inc. to buy US-based Reata Pharmaceuticals for $7.3 billion

HQ Team July 29, 2023: Biogen Inc., a US-based biotechnology company, will acquire Reata Pharmaceuticals for $7.3 billion to expand its neurological portfolio,.

Read More